---
title: "Designing Microbiome Trials: Gut Microbiota for Health World Summit 2022"
subtitle: ""
author: "Brendan J. Kelly, MD, MS"
institute: "Infectious Diseases & Epidemiology<br><br>![](penn_logos/Penn-Shield-Logotype-White-over-Blue-RGB-Expanded.svg){width=160px}" 
date: "12 March 2022" #"`r format(Sys.Date(), '%d %B %Y')`"
output:
  xaringan::moon_reader:
    css: xaringan-themer-inferno-grids-fade.css
    lib_dir: libs
    chakra: libs/remark-latest.min.js
    seal: false
    nature:
      ratio: 16:9
      highlightStyle: github
      highlightLines: true
      countIncrementalSlides: false
      slideNumberFormat: "%current%"

---
exclude: true

```{r setup, include=FALSE, echo=FALSE, message=FALSE, error=FALSE, include=FALSE, comment=FALSE}
options(htmltools.dir.version = FALSE)
xaringan::summon_remark()
library(tidyverse)
library(gt)

```

```{r xaringan-tile-view, echo=FALSE, message=FALSE, error=FALSE, include=FALSE, comment=FALSE}
xaringanExtra::use_tile_view()
xaringanExtra::use_webcam()
xaringanExtra::use_tachyons()
xaringanExtra::use_animate_css()
xaringanExtra::use_share_again()
#xaringanExtra::use_scribble(pen_color = "#56106E")
```

---
class: top left hide-count
background-image: url(img/cdc-QEU-QgIOJKA-unsplash_dark.jpg)
background-size: cover

.move-top20[
.title-text[<span style='font-size:0.75em'>Designing Microbiome Trials</span>]  
.title-subtext[<span style='font-size:1.2em'>Unique Challenges & Considerations</span>]  
]  
  
.callout-url-leftcorner[
.title-nametext[
Brendan J. Kelly, MD, MS  
Infectious Diseases & Epidemiology  
University of Pennsylvania  

GMFH World Summit  
12 March 2022
]
]

.footnote-right[<span style='color: white'>photo: CDC @unsplash</span>]  



---

## Disclosures  

.pad-left[  

- No conflicts of interest.  

- Research supported by:

    - NIAID K23 AI121485  
    
    - CDC BAA 200-2016-91964  
    
    - CDC BAA 200-2016-91937  
    
    - CDC BAA 200-2018-02919  
    
    - CDC BAA 200-2021-10986   

]


---

## Understanding and Misunderstanding RCTs  

.pad-left[  
  
- Randomized controlled trials = gold standard for clinical research:    
  
    - balance known & unknown confounders       
    
    - powerful tool for causal inference    
        
- RCTs can still mislead us:  

    - selection bias (subjects ≠ population)

    - "trial interventions are interactions"  
    (subject features modify effect of trial intervention)

    - "subjects aren't even representative of themselves"  
    (time-varying features can interact with trial intervention)
   
]

.footnote-left[Deaton & Cartwright _Social Science & Medicine_ 2018; Andrew Gelman] 


---

## The Promise of Fecal Microbiota Transplant (FMT)    
  
.pad-left[  
  
- How do antibiotics fail?  
  
    - failure of pathogen identification → wrong antibiotic       
    
    - high-grade phenotypic resistance or inadequate source control    
    
    - <u>post-antibiotic repopulation</u>  
    
- Bacterial ecology of infection: VAP, _C. difficile_  
  
- Microbiome change during & after antibiotics   
  
- Engineering post-antibiotic repopulation      
  
    
]  



---

## Repopulation & Recurrent Infection      
  
.pad-left[  
  
- Why does <u>post-antibiotic repopulation</u> matter?    

- Failed repopulation risks recurrent infection:  

    - healthy subjects time to post-antibiotic repopulation ~ 3 months
    
    - recurrent _C. difficile_ infection (R-CDI): ~ 20% post-treatment recurrence
  
    - bloodstream, respiratory and urinary tract infections?     
    
    
]  

.footnote-left[Blaser _Science_ 2016; Raymond et al _ISME J_ 2016; Kelly & Tebas _Chest_ 2018; Al-Hasan et al _J Infect_ 2010; Jensen et al _CMI_ 2011; Munoz et al _CMI_ 2016]  


---
exclude: true

## Repopulation & Recurrent Infection      
  
.pad-left[  
  
- Study of post-infection recurrence:  

    - 10,855 heme-onc patients admitted to HUP from 2010-2011      

    - 7819 (72%) with blood, respiratory, or urine culture obtained
    
    - 1042 (9.6%) +blood cx, 215 (2.0%) +resp cx, 845 (7.8%) +urine cx  
    
    - same genus recurrence: 286 (28.6%) blood, 58 (29.0%) resp, 272 (34.0%) urine  
    
    - other genus recurrence: 208 (20.8%) blood, 35 (17.5%) resp, 88 (11.0%) urine  
    
    - examine time to post-infection recurrence ...       
  
    
]  

.footnote-left[Ziegler MJ et al. Submitted.]  


---

## Repopulation & Recurrent Infection      
  
.pad-left[  
  
- Study of post-infection recurrence:  

    - 10,855 heme-onc patients admitted to HUP from 2010-2021      

    - 7819 (72%) with blood, respiratory, or urine culture obtained:  
    
```{r, warning=FALSE, error=FALSE, echo=FALSE, message=FALSE}

tribble(~ "Infection", ~ "Total Subjects", ~ "Recurrent - Same Genus", ~ "Recurrent - Different Genus",
        "Bloodstream", "1042 (9.6%)", "286 (28.6%)", "208 (20.8%)",
        "Respiratory", "215 (2.0%)", "58 (29.0%)", "35 (17.5%)",
        "Urine", "845 (7.8%)", "272 (34.0%)", "88 (11.0%)") %>%
  gt() %>%
  tab_options(column_labels.font.size = 20,
              column_labels.font.weight = "bold",
              table.font.size = 20)

```
  
- Examine time to post-infection recurrence ...       
  
]  

.footnote-left[Ziegler MJ et al. Manuscript in preparation.]  


---
background-image: url(figs/p_hurdle_gap_same_vs_other_genus_tp.png)
background-size: contain



.footnote-left[Ziegler MJ et al. Manuscript in preparation.]


---
background-image: url(figs/p_hurdle_gap_same_genus_f_cxtype_r_genus_after14_tp.png)
background-size: contain



.footnote-left[Ziegler MJ et al. Manuscript in preparation.]



---
background-image: url(figs/p_abx.png)
background-size: contain



.footnote-left[Ziegler MJ et al. Manuscript in preparation.]



---

## Future Directions      
  
.pad-left[  
  
- <u>Post-antibiotic repopulation</u>:      

    - demographic features → recurrent infection risk  
    
    - oncology diagnosis → recurrent infection risk  
    
    - antibiotic exposure → repopulation → recurrent infection risk  


]  

.footnote-left[Davar et al _Science_ 2021; Schubert et al _Frontiers Immun_ 2021; Cubillos-Ruiz et al _Nat Rev Drug Disc_ 2021]  



---

## Work to Understand Repopulation        
  
.pad-left[  
  
- Bacterial ecology of infection:

    - ventilator-associated pneumonia (VAP)  
    
    - _C. difficile_ infection  
  
- Microbiome change during & after antibiotics    
  
- Engineering post-antibiotic repopulation:  

    - antibiotic conditioning & transplant  
    
    - *post-induction consolidation therapy with bacteriophage*    
  
]  


---
exclude: true

## Acknowledgements    

.pull-left[
- __ARES Group @ Penn__
Sean Loughrey, Laura Cowden, Laurel Glaser, Kyle Rodino,   
Magda Wernovsky, Emily Reesey, Erik Clarke, Michael David,
Matt Ziegler, Lauren Dutcher, Ebbing Lautenbach, Jim Harrigan, Hatem Abdallah

- __Bushman Laboratory @ Penn__
Arwa Abbas, Aoife Roche, Andrew Marques,
Aubrey Bailey, Jacob Leiby,
Rick Bushman

- __PennCHOP Microbiome Program__
Lisa Mattei, Casey Hofstaedter, Huanjia Zhang, Kyle Bittinger

]


.pull-right[
- __Collman Laboratory @ Penn__
Ize Imai, Aurea Simon Soro, John McGinniss, Ron Collman

- __Division of ID @ Penn__
Ian Frank, Pablo Tebas, Robert Gross, Emily Blumberg

- __Rutgers University & Penn DBEI__
Jason Roy, Arman Oganisian
  
- __CDC Prevention Epicenters__
Clifford McDonald, Alison Laufer Halpin
  
- __Funding__
<u>CDC</u>: BAAs 200-2016-91964, 200-2018-02919, 200-2021-10986,
200-2021-10986 & <u>NIAID</u>: K23 AI121485

]

.center[
### brendank@pennmedicine.upenn.edu
]



---
class: middle center hide-count
background-image: url(img/cdc-QEU-QgIOJKA-unsplash_dark.jpg)
background-size: cover

.title-subtext[Questions?]

.callout-url-bottom[  
.fade-in[<span style="font-size:0.5em; color:white">slides ↓ </span>]  
<span style="link-color:white">[bjklab.org](http://www.bjklab.org)</span>  
]  


